New Jersey's Opioid Crisis: One of the Northeast's Most Affected States

New Jersey has been one of the hardest-hit states in the American opioid epidemic for more than two decades. From the shore towns of Monmouth County to the urban neighborhoods of Camden and Newark, families in every corner of the Garden State have been touched by addiction, overdose, and loss. Understanding the scope of this crisis — and the resources available — is the first step toward getting help.

The Scale of the Crisis in New Jersey

The numbers are stark. According to the New Jersey Division of Mental Health and Addiction Services (DMHAS), the state has consistently recorded more than 3,000 drug overdose deaths per year in recent years. The Centers for Disease Control and Prevention (CDC) tracks New Jersey among the top states in the Northeast for overdose mortality rates, and the National Institute on Drug Abuse (NIDA) identifies synthetic opioids — primarily illicit fentanyl — as the driving force behind the most recent surge in deaths.

The Substance Abuse and Mental Health Services Administration (SAMHSA) reports that opioid use disorder (OUD) affects hundreds of thousands of New Jersey residents at any given time, yet the majority never receive treatment. Stigma, lack of insurance, geographic barriers, and simple uncertainty about where to turn all contribute to this treatment gap.

How the Crisis Evolved

New Jersey’s opioid problem did not emerge overnight. In the late 1990s and early 2000s, aggressive marketing of prescription painkillers like OxyContin flooded the state’s medicine cabinets. Overprescribing by physicians — many acting in good faith based on misleading pharmaceutical industry claims — led to widespread physical dependence. When federal and state regulators began cracking down on pill mills and prescription monitoring, many people who had become dependent on prescription opioids turned to heroin, which was cheaper and more readily available in New Jersey’s proximity to major drug trafficking corridors.

By the mid-2010s, heroin had been largely displaced by fentanyl and its analogs — synthetic opioids up to 100 times more potent than morphine. Fentanyl is now found not only in the heroin supply but increasingly in counterfeit pills sold as oxycodone, Xanax, and even stimulants. This means people who have never intentionally used an opioid can encounter lethal fentanyl doses without knowing it.

Which Counties Are Most Affected?

While the opioid crisis has touched all 21 of New Jersey’s counties, DMHAS data consistently shows the heaviest burden in:

Camden County — Camden city has long faced high rates of poverty, unemployment, and overdose. Proximity to Philadelphia’s drug markets contributes to supply challenges.

Essex County — Newark and surrounding municipalities have high overdose call volumes. Essex County has invested significantly in harm reduction and naloxone distribution.

Ocean County — Despite its suburban and shore town character, Ocean County has consistently ranked among the state’s highest for overdose deaths per capita, reflecting the opioid crisis’s reach into middle-class communities.

Middlesex and Union Counties — These densely populated central New Jersey counties see high volumes of overdose emergency calls due to population density and regional drug distribution patterns.

Passaic and Hudson Counties — Urban poverty, transient populations, and proximity to New York City drug markets create persistent challenges.

Rural and suburban counties are not immune. Hunterdon, Sussex, and Warren counties have all seen significant increases in overdose deaths as fentanyl has spread beyond urban centers.

The Fentanyl Problem

Fentanyl has fundamentally changed the danger calculus of opioid use in New Jersey. According to CDC data, synthetic opioids were involved in more than 80% of the state’s overdose deaths in recent reporting years. Because illicit fentanyl is manufactured without quality controls, potency varies wildly from batch to batch — even from one end of a single batch to another. This unpredictability makes every use potentially fatal, even for people with high opioid tolerance.

NIDA research underscores that fentanyl’s extreme potency means overdose can occur within minutes of exposure, faster than bystanders can often recognize what is happening. This is why naloxone (Narcan) availability is so critical: multiple doses may be needed, and calling 911 immediately is essential.

New Jersey’s Response

New Jersey has implemented several significant policy responses to the opioid crisis. The state’s Opioid Recovery and Remediation Fund, established with proceeds from opioid litigation settlements, channels money into prevention, treatment, and recovery support services. DMHAS operates a system of county-based addiction services that includes assessment, referral, and funding assistance for low-income residents.

New Jersey has also expanded naloxone access, making it available without a prescription at pharmacies statewide. The state’s harm reduction programs distribute naloxone, clean syringes, and fentanyl test strips in many counties. Additionally, New Jersey was an early adopter of medication-assisted treatment (MAT) requirements in state-licensed facilities, recognizing that buprenorphine and methadone are the gold standard for opioid use disorder treatment.

The NJ Opioid Monitoring System tracks overdose data in near-real-time, allowing public health officials to identify and respond to spikes before they become mass casualty events.

Barriers to Treatment

Despite robust resources, significant barriers remain. SAMHSA surveys consistently find that stigma is the number-one reason people with substance use disorders do not seek treatment. Many New Jersey residents report fear of judgment from family, employers, or the legal system as a primary deterrent.

Geographic barriers affect residents in more rural counties, where treatment facilities may be far from home or public transportation. Waitlists for methadone clinics and residential programs — particularly in Essex, Camden, and Hudson counties — can stretch for weeks. And while NJ FamilyCare (the state’s Medicaid program) covers substance use disorder treatment, navigating the insurance system can be daunting for someone in crisis.

What You Can Do Right Now

If you or someone you love is struggling with opioid addiction in New Jersey, there are immediate steps you can take:

Call SAMHSA’s National Helpline at 1-800-662-4357, available 24/7, free and confidential, with translation services.
Access DMHAS’s Addiction Services Locator at nj211.org to find treatment options in your county.
Obtain naloxone from any New Jersey pharmacy without a prescription — it can reverse an overdose and save a life.
Call 911 immediately if you witness an overdose. New Jersey’s Overdose Prevention Act provides legal protection for people who call for help.

Recovery from opioid addiction is possible. Tens of thousands of New Jersey residents are living proof. Evidence-based treatments including buprenorphine, methadone, and naltrexone, combined with counseling and peer support, produce recovery outcomes that rival treatment success rates for other chronic diseases.

Ready to Get Help?

If you or a loved one is struggling with opioid addiction in New Jersey, you don’t have to face it alone. Our confidential hotline connects you with trained specialists who understand New Jersey’s treatment landscape and can help you take the next step — whether that’s finding a detox program, understanding your insurance coverage, or simply having someone to talk to.

Call the New Jersey Addiction Hotline now. Help is available 24 hours a day, 7 days a week. Your call is free, confidential, and could be the most important one you ever make.